@article{article, keywords = {Chagas disease, Cost effectiveness, Chronic Disease, Decision Trees, Internship and Residency, Italy, Primary healthcare, Quality-Adjusted Life Years, public health medicine, Health outcomes, Health care systems, Cost-effectiveness analysis, medical residencies, Community, Sensitivity analysis, Treatment effectiveness}, author = {Marraffa P and Marega L and Gianino M}, title = {Cost-effective but underused: evaluating screening strategies for indeterminate Chagas disease}, abstract = {
Background
Chagas disease is a burdensome condition in non-endemic countries, yet underdiagnosed and underestimated. We aimed to assess cost-effectiveness of alternative screening models in Latin American residents in Italy.
Methods
A decision-analytic model combining a decision tree and a Markov model (annual cycles) was developed to simulate the lifetime progression of chronic disease. Four strategies were compared: usual care (no systematic screening), community-based active screening and two primary care{\textendash}based approaches (standard and enhanced). Outcomes included costs, quality-adjusted life years (QALYs), incremental cost-effectiveness ratios (ICERs) and net monetary benefit (NMB), from a healthcare system perspective, using a {\texteuro}30,000/QALY threshold. Deterministic and probabilistic sensitivity analyses assessed robustness.
Results
Preliminary results estimated that all screening strategies were cost-effective compared with usual care, with ICERs below the threshold. In the base-case analysis, ICERs were {\texteuro}8,397/QALY for active screening, {\texteuro}14,249/QALY for standard primary care and {\texteuro}7,360/QALY for enhanced primary care. Per 10,000 individuals, active screening generated the largest health gains (+101 QALYs) even if with higher incremental costs ({\texteuro}850,478). Deterministic sensitivity analysis was primarily driven by disease prevalence and treatment effectiveness, probabilistic analysis confirmed robustness, with mean ICERs of {\texteuro}24,140/QALY (active screening) and {\texteuro}21,551/QALY (enhanced primary care) and probabilities of cost-effectiveness of 89.1\% and 90.1\%, respectively.
Conclusions
The lack of systematic screening for Chagas disease in migrants is a missed opportunity to improve health outcomes and resource use. Community-based approaches maximise health gains, while strengthened primary care offers a resource-efficient and scalable option. These findings support the integration of Chagas screening into routine public health and primary care services in Europe.\
}, year = {2026}, journal = {European Journal of Public Health}, volume = {36}, month = {10/2026}, publisher = {Oxford University Press (OUP)}, issn = {1464-360X}, url = {https://academic.oup.com/eurpub/article-pdf/36/Supplement_5/ckag169.394/72463033/ckag169.394.pdf}, doi = {10.1093/eurpub/ckag169.394}, language = {ENG}, }